Filing Details

Accession Number:
0001437749-15-011668
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-02 16:55:55
Reporting Period:
2015-06-01
Filing Date:
2015-06-02
Accepted Time:
2015-06-02 16:55:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1586049 Oxford Immunotec Global Plc OXFD In Vitro & In Vivo Diagnostic Substances (2835) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1245055 A Richard Sandberg C/O Oxford Immunotec Global Plc
94C Innovation Drive
Abingdon, Oxfordshire X0 OX14 4RZ
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2015-06-01 1,100 $14.23 47,074 No 4 S Direct
Ordinary Shares Disposition 2015-06-01 300 $14.22 46,774 No 4 S Direct
Ordinary Shares Disposition 2015-06-01 200 $14.21 46,574 No 4 S Direct
Ordinary Shares Disposition 2015-06-01 100 $14.12 46,474 No 4 S Direct
Ordinary Shares Disposition 2015-06-01 100 $14.07 46,374 No 4 S Direct
Ordinary Shares Disposition 2015-06-01 390 $14.05 45,984 No 4 S Direct
Ordinary Shares Disposition 2015-06-01 210 $14.04 45,774 No 4 S Direct
Ordinary Shares Disposition 2015-06-01 100 $14.03 45,674 No 4 S Direct
Ordinary Shares Disposition 2015-06-01 100 $14.02 45,574 No 4 S Direct
Ordinary Shares Disposition 2015-06-01 100 $14.01 45,474 No 4 S Direct
Ordinary Shares Disposition 2015-06-01 200 $14.01 45,274 No 4 S Direct
Ordinary Shares Disposition 2015-06-01 100 $14.00 45,174 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5 trading plan adopted by the reporting person on August 22, 2014.